LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply
AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.
-
Filed today
-
Companies tracked
NSE & BSE
Listed on
👋Welcome back, there - you're tracking 0 companies
🔔Sign in free to track companies and get alerts the moment they file
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors
Latest Filings -
📋 Filing Types Available on ForgeUp Filings
Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
The company used the money raised from its Rights Issue exactly as planned, without any changes.
🤖 AI Summary
Camlin Fine Sciences confirmed no deviation in Rights Issue fund utilization for quarter ended March 31, 2026.
Monitoring Agency Report by India Ratings & Research Private Limited was reviewed and approved.
Total amount received in Escrow account for Rights Issue was INR 22,468.39 Lakhs.
This amount from 2,04,25,805 Equity Shares was 100% utilized as of March 31, 2026.
The report confirms utilization aligns with objects stated in the Letter of Offer.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Issue Size
INR 22,468.87 Lakhs
Amount Received in Escrow a/c
INR 22,468.39 Lakhs
Equity Shares Issued
2,04,25,805 Equity Shares
Fund Utilization as on March 31, 2026
100%
🏢 How This Affects the Company
💰
Financial Impact
The company has fully utilized INR 22,468.39 Lakhs from the Rights Issue proceeds by March 31, 2026, for its stated objectives.
⚠️
Risk Impact
Confirmation of no deviation in fund utilization reduces financial execution risk associated with the Rights Issue proceeds.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this compliance filing.
👤
Who Is Affected
All shareholders are informed that the funds raised through the Rights Issue of 2,04,25,805 Equity Shares have been utilized according to plan.
🔍
Management Signal
The filing indicates management's adherence to regulatory requirements and commitment to utilizing raised capital for its specified objectives.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Next quarterly monitoring agency report for subsequent fund utilization periods.
Company's next financial results to observe impact of utilized funds.
Further updates on projects or initiatives funded by the Rights Issue.
LOW RISKThe filing confirms compliance with fund utilization, reducing risk of misuse or deviation.
💡 Investor Takeaway
Camlin Fine Sciences confirmed 100% utilization of INR 22,468.39 Lakhs from its Rights Issue proceeds as of March 31, 2026. The monitoring agency verified no deviation from the stated objects outlined in the Letter of Offer.
⚖️ Strengths & Concerns
✅ Positives
100% utilization of Rights Issue proceeds amounting to INR 22,468.39 Lakhs by March 31, 2026, for stated objects.
Independent monitoring agency, India Ratings & Research, confirmed no deviation from stated objects, enhancing transparency.
📅 Company Track Record
No previous specific filings related to fund utilization details or significant corporate actions for Camlin Fine Sciences Ltd were provided in the past filings context.
Based on publicly available historical data. For context only.
All BSE filings we have analysed for Camlin Fine Sciences Ltd.
You've read one filing
There are 32,000 more, and one of them is about a company you own
Follow a company and we'll email you the moment it files
again - explained, not just forwarded. Free.
Follow companies and get filings by email
Save any filing to read later
Two full AI analyses every month, free
No card needed. Sign in with Google in two taps.
⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔖
Save filings you care about
Sign in free to save any filing and get notified when the same company files again.
🔖
Save This Filing
Sign in with Google to save this filing and get notified when this company files again. Free, takes 5 seconds.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.